While some individuals may benefit from medications targeting substance cravings or withdrawal symptoms, others may require psychiatric medications to manage mood and anxiety disorders 24,25,26,27. The careful selection and monitoring of medications, along with ongoing evaluation of their effectiveness, are crucial aspects of treatment 28. By leveraging the potential benefits of pharmacological interventions within a broader treatment framework, we can optimize outcomes for individuals with dual diagnoses 32,33.

It raises doubts about their safety and efficacy, as the two forms of addiction may not necessarily share the same biological underpinnings. prevention of substance use and mental disorders Despite these challenges, the serial care approach still offers valuable insights that can significantly inform our understanding and treatment of concurrent disorders. One illuminating concept in this approach, often likened to a “Trojan Horse”, has been articulated by experts such as Dr. Anna Lembke, a prominent psychiatrist directing the Stanford University Concurrent Disorders Program. In this ancient story, the Greeks used a massive wooden horse as a deceptive strategy to gain entry into the city of Troy. Similarly, in the field of concurrent disorders, some patients enthusiastically engage with concurrent disorder programs with a similar notion.

World mental health report: Transforming mental health for all

NIMH statistics pages include statistics on the prevalence, treatment, and costs of mental illness for the population of the United States. Interventions in adulthood for the prevention of SUD focus on screening, early detection of problematic patterns of substance use, and brief interventions for the same and referral to specialist treatment where indicated. Talk with a doctor to find out what types of treatments are available in your area and what options are best for you and/or your loved one. Addiction is a chronic disease; be sure to ask your doctor about the risk of returning to use and overdose. Opioid use disorder treatment can vary depending the patient’s individual needs, occur in a variety of settings, take many different forms, and last for varying lengths of time. Information about resources such as data, tissue, model organisms and imaging resources to support the NIMH research community.

The goal of this exercise is neither to provide an exhaustive list of all possible interventions, nor to grade the available evidence for various interventions. Instead, the focus is specifically to provide a socioecological public health prevention framework to support a holistic vision for OUD policy, research, and service delivery solutions. Additionally, the socioecological foundation of this framework will foster adaptable and effective solutions that are responsive to the underlying needs of those who are most affected by OUD. Leading public health thinkers have consistently connected socioeconomic factors to illness, while some traditional clinical medicine professionals have held views restricted to the somatic parameters and “the organic elements . The biomedical model described in the latter half of the previous sentence forms the basis of classical Western medical training, in which illness can be reduced to a biological or physiological physical element. Rudolf Virchow (1848), considered the father of modern pathology, stated that “medicine is a social science” and understood that disease operates at the cellular level.

RELATED RESOURCES

The U.S. Preventive Services Task Force (USPSTF) recommends that all adults be screened for unhealthy substance use.2 Screening should be universal and not based solely on clinical suspicion, which can be biased and miss patients who need our help. A variety of tools with validation can be administered prior to the encounter with the provider, allowing for further discussion if the screen was positive. The following screeners, except the DAST, are publicly available, free to use and can be found on the PCL website Resources page. Learn about NIMH priority areas for research and funding that have the potential to improve mental health care over the short, medium, and long term. For additional examples of socioecological primary prevention interventions for OUD, please refer to Table A-1.

It suggests that alcohol use may represent a separate, concurrent issue rather than being exclusively attributable to an underlying psychiatric illness. This nuanced perspective reevaluates SUDs as distinct illnesses that do not always have a direct causal link to another psychiatric disorder. Instead, it underscores their concurrent nature, recognizing that these disorders can coexist independently, and one may not necessarily be a direct consequence of the other. If a patient does screen positive, the style in which the patient is engaged in discussion about diagnosis and treatment is critical to engaging patients successfully in care.

Supporting Patients with Substance Use Disorders

Effectively addressing comorbid SUDs and psychiatric conditions demands a comprehensive treatment approach 12,14. Among the various treatment strategies available, current evidence strongly supports an approach known as integrated care. Integrated care, also referred to as parallel or comprehensive care, entails the simultaneous provision of treatment for all co-occurring disorders an individual may experience.

Research Conducted at NIMH (Intramural Research Program)

The Society for Prevention Research has played an important role by providing a yearly conference and an excellent journal, Prevention Science, and by articulating positions on the importance of high quality prevention research. Another important focus is the increasing awareness of the need for effective dissemination and implementation of evidence-based preventions. It is through effective dissemination and implementation, prevention programs can have a population-level effect. However, effective dissemination and implementation of prevention programs are not possible without sufficient funding and research. The study of, dissemination, and implementation of prevention initiatives has come to be recognized as an important scientific endeavor. To succeed, state and local governments will need to invest in a robust information technology infrastructure that can better model population health and allow for rigorous evaluation of interventions.

However, integrated care transcends the realms of medication and psychotherapy, encompassing a broader spectrum of care domains that address clients’ individual biopsychosocial needs. For instance, in cases where clients face significant social inequities, the inclusion of interventions such as access to stable housing, financial support, and peer support becomes equally as vital and impactful as medications or interactions with a psychiatrist. Integrated care recognizes that these external factors play a pivotal role in an individual’s overall well-being and treatment outcome 16. To that end, the treatment of individuals with comorbid SUDs and psychiatric disorders necessitates a comprehensive and integrated care approach 17.

Also, search SAMHSA’s Evidence-Based Practices Resource Center to find evidence-based programs related to prevention and early intervention for all behavioral health issues. People have biological and psychological characteristics that can make them vulnerable or resilient to potential behavioral health problems. Individual-level protective factors might include a positive self-image, self-control, or social competence. Some clinicians believe that when patients report a calming or focusing effect from using illicit stimulants, such as methamphetamines or cocaine, instead of experiencing euphoria, it suggests that they have ADHD. However, this hypothesis also lacks an evidence base and may be influenced by bias, especially in cases where patients seek stimulants for secondary gain. Key factors—such as the high prevalence of illicitly manufactured opioids, the counterproductive role of prohibition policies in creating an increasingly toxic drug supply, and evolving trends in substance use—have been largely overlooked.

More than 20 million adults and adolescents in the United States have had a substance use disorder in the past year.1 Healthy People 2030 focuses on preventing drug and alcohol misuse and helping people with substance use disorders get the treatment they need. To counter the prevailing erroneous theories of addiction as a moral failing, the medical community put forth the brain disease model, which expressed addiction in scientific terms, namely explaining that SUD resulted from a brain system that had been dysregulated by drug use (Heilig et al., 2021; Leshner, 1997). However, the mechanistic view of drugs “hijacking” the brain was not in conflict with the interdiction paradigm that similarly targeted drugs as the source of growing social ills.

Therefore, further research is necessary to assess the effectiveness of harm reduction interventions specifically tailored to individuals grappling with both SUDs and psychiatric disorders. Embracing harm reduction as a fundamental principle of care ensures that we meet individuals where they are on their journey toward recovery, offering a compassionate and effective pathway that recognizes the complexities of dual diagnosis scenarios. MI fosters intrinsic motivation for change and aids individuals in exploring their ambivalence towards substance use and mental health management. The effectiveness of 12-step group facilitation interventions, such as Alcoholics Anonymous (AA), in addressing SUDs, particularly alcohol use disorder (AUD), is supported by high-quality evidence 57, showing their efficacy in promoting abstinence. For instance, Cochrane reviews have consistently highlighted the insufficiency of evidence to establish the effectiveness of certain psychotherapies for various SUDs, whether accompanied by comorbidity or not. An example of this shortfall is the inadequacy of high-quality research regarding the effectiveness of CBT in the treatment of stimulant use disorders 47,48,58.

ETIOLOGY OF SUD

He also recognized the social conditions that facilitated the spread of disease, yet this acknowledgment had minimal influence in the evolution of the biomedical model. SAMHSA has demonstrated that behavioral health is essential to health, prevention works, treatment is effective, and people recover from mental and/or substance use disorders. Experts attest that an optimal mix of prevention interventions is required to address substance use issues in communities because they are among the most difficult social problems to prevent or reduce. SAMHSA’s program grantees should consider comprehensive solutions that fit the particular needs of their communities and population, within a cultural context and take into consideration unique local circumstances, including community readiness. Some interventions may be evidence-based, while others may document their effectiveness based on other sources of information and empirical data. To treat those with opioid use disorder, it is crucial to expand access to evidence-based treatments, including medications for opioid use disorder (MOUD).

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *